EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic and prognostic significance of circulating secreted frizzled‐related protein 5 in colorectal cancer

Runhao Li iD, Saifei Liu, Kenny Yeo, Suzanne Edwards, Man Ying Li, Ryan Santos, Sima Kianpour Rad, Fangmeinuo Wu, Guy Maddern, Joanne Young, Yoko Tomita, Amanda Townsend und 4 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.7352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Runhao Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, Austral…. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Biomarkers, Tumor, Colorectal Neoplasms. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AusHealth.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Secreted Frizzled‐Related Protein 5 (SFRP5) modulates Wnt signalling pathways, affecting diverse biological processes. We assessed the diagnostic and prognostic value of circulating SFRP5 (cSFRP5) in colorectal cancer (CRC)

Methods

Plasma cSFRP5 concentrations were measured using enzyme‐linked immunosorbent assay (ELISA) in healthy donors ( n = 133), individuals diagnosed with CRC ( n = 449), colorectal polyps ( n = 85), and medical conditions in other organs including cancer, inflammation, and benign states ( n = 64).

Results

Patients with CRC, polyps, and other conditions showed higher cSFRP5 levels than healthy individuals ( p < 0.0001). Receiver operating characteristic curves comparing healthy donors with medical conditions, polyps and CRC were 0.814 ( p < 0.0001), 0.763 ( p < 0.0001) and 0.762 ( p < 0.0001), respectively. In CRC, cSFRP5 correlated with patient age ( p < 0.0001), tumour stage ( p < 0.0001), and histological differentiation ( p = 0.0273). Levels, adjusted for patient age, sex, plasma age and collection institution, peaked in stage II versus I ( p < 0.0001), III ( p = 0.0002) and IV ( p < 0.0001), were lowest in stage I versus III ( p = 0.0002) and IV ( p = 0.0413), with no difference between stage III and IV. Elevated cSFRP5 levels predicted longer overall survival in stages II‐III CRC (univariate: HR 1.82, 95% CI: 1.02–3.26, p = 0.024; multivariable: HR 2.34, 95% CI: 1.12–4.88, p = 0.015).

Conclusion

This study confirms cSFRP5 levels are elevated in CRC compared to healthy control and reveals a correlation between elevated cSFRP5 and overall survival in stages II‐III disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingBiomarkers, TumorColorectal NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedCase-Control StudiesNeoplasm StagingPrognosisROC CurveSecreted Frizzled-Related Proteins

Stichwörter der Autor:innen

SFRP5colorectal cancerdiagnosisplasma biomarkerprognosis

Substanzen

Adaptor Proteins, Signal TransducingBiomarkers, TumorSFRP5 protein, humanSecreted Frizzled-Related Proteins

Autor:innen und Institutionen

  • Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.
  • Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
  • Discipline of Surgery, The University of Adelaide, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.
  • School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.
  • Viral Immunology Group, The University of Adelaide and Basil Hetzel Institute for Translational Health Research, Woodville, South Australia, Australia.
  • Medical Oncology, The Queen Elizabeth Hospital, Woodville, South Australia, Australia.

ORCID-Profile: Runhao Li, Timothy Price, Eric Smith

Förderung

  • AusHealth

Zitieren

APA

Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., Rad, S. K., Wu, F., Maddern, G., Young, J., Tomita, Y., Townsend, A., Fenix, K., Hauben, E., Price, T., & Smith, E. (2024). Diagnostic and prognostic significance of circulating secreted frizzled‐related protein 5 in colorectal cancer. Cancer Medicine. https://doi.org/10.1002/cam4.7352

Vancouver

Li R, Liu S, Yeo K, Edwards S, Li MY, Santos R, et al. Diagnostic and prognostic significance of circulating secreted frizzled‐related protein 5 in colorectal cancer. Cancer Medicine. 2024. doi:10.1002/cam4.7352

BibTeX
@article{Li2024,
  author = {Li, Runhao and Liu, Saifei and Yeo, Kenny and Edwards, Suzanne and Li, Man Ying and Santos, Ryan and Rad, Sima Kianpour and Wu, Fangmeinuo and Maddern, Guy and Young, Joanne and Tomita, Yoko and Townsend, Amanda and Fenix, Kevin and Hauben, Ehud and Price, Timothy and Smith, Eric},
  title = {Diagnostic and prognostic significance of circulating secreted frizzled‐related protein 5 in colorectal cancer},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7352}
}
Kostenlos starten →